Toward the identification of peripheral epigenetic biomarkers of schizophrenia

Journal of Neurogenetics

Volumn 28, Issue 1-2, 2014, Pages 41-52

  Guidotti, A ^a   Auta, J ^a   Davis, J M ^a   Dong, E ^a   Gavin, D P ^a,b   Grayson, D R ^a   Sharma, R P ^a,b   Smith, R C ^c   Tueting, P ^a   Zhubi, A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain derived nerve growth factor; DNA methylation; Glucocorticoid receptor; Lymphocytes

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYCYTOSINE TRANSLOCATOR PROTEIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE; GLUCOCORTICOID RECEPTOR; GLUTAMATE DECARBOXYLASE 67; NEUROLEPTIC AGENT; TEN ELEVEN TRANSLOCASE PROTEIN; UNCLASSIFIED DRUG;

AUTOPSY; CLINICAL RESEARCH; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; FEASIBILITY STUDY; GENETIC RISK; GENETIC TRANSCRIPTION; HIGH RISK PATIENT; HUMAN; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; BLOOD; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; LYMPHOCYTE; METABOLISM;

BIOLOGICAL MARKERS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE REGULATORY NETWORKS; HUMANS; LYMPHOCYTES; SCHIZOPHRENIA;

EID: 84901400390     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2014.892485     Document Type: Review

References (90)

1. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., & Gao F. (2006). Hypomethylation of MBCOMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet, 15, 3132-3145. (Pubitemid 44607800)
2. Abdolmaleky, H. M., Cheng, K. H., Russo, A., Smith, C. L., Faraone, S. V., & Wilcox M. (2005). Hypermethylation of reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report. Am J Med Genet B Neuropsychiatry, 134B, 60-66. (Pubitemid 40411111)
3. Addington, J., Cornblatt, B., Cadenhead, K. S., Cannon, T. D., McGlashan, T. H., Perkins, D. O., Seidman, L. J., et al. (2011). At clinical high risk for psychosis: Outcome for nonconverters. Am J Psychiatry, 168, 800-805.
4. Akbarian, S., Kim, J. J, Potkin, S. G, Hagman, J. O, Tafazzoli, A., Bunney, W. E. (1995). Gene expression for Glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry, 52, 258-266.
5. Auta, J., Smith, R. C., Dong, E., Tueting, P., Sershen, H., & Boules, S. (2013). DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients. Schizophr Res, 150, 312-318.
6. Benes, F. M., & Berretta, S. (2001). GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder [review]. Neuropsychopharmacology, 25, 1-27. (Pubitemid 32493819)
7. Benes, F. M., Sorensen, I., Vincent, S. L., Bird, E. D., & Sathi, M. (1992). Increased density of glutamateimmunoreactive vertical processes in superfi cial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex, 2, 503-512.
8. Bhutani, N., Burns, D. M., & Blau, H. M. (2011). DNA demethylation dynamics. Cell, 146, 866-872.
9. Bocklandt, S., Lin, W., & Sehl, M. E. (2011). Epigenetic predictors of age. PLoS ONE, 6, e14821.
10. Braff, D. L. (2011). Gating in schizophrenia: From genes to cognition (to real world function). Biol Psychiatry, 69, 395-396.
11. Bromberg, A., Levine, J., Nemetz, B., Belmaker, R. H., & Agam, G. (2008). No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr Res, 101, 50-57.
12. Carrad, A., Salzmann, A., Malafosse, A., & Karege, F. (2011). Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord, 132, 450-453.
13. Chan, M. K., Guest, P. C., Levin, Y., Umrania, Y., Schwarz, E., Bahn, S., & Rahmoune, H. (2011). Converging evidence of blood-based biomarkers for schizophrenia: An update. Int Rev Neurobiol, 101, 95-144.
14. Chase, K. A., Gavin, D. P., Guidotti, A., & Sharma, R. P. (2013). Histone methylation at H3K9: Evidence for a restrictive epigenome in schizophrenia. Schizophr Res, 149, 15-20.
15. Christensen, B. C., Housmen, E. A., Marsit, C. J., et al. (2009). Aging and environmental exposures alter tissue specifi c DNA methylation dependent upon CpG island context. PLoS Genet, 5, e1000602.
16. Cordero, P., Gomez-Uriz, A. M., Campion, J., Milagro, F. I., & Martinez, J. A. (2013). Dietary supplementation with methyl donors reduces fatty liver and modifi es the the fatty acid synthase DNA methylation profi le in rats fed on obesogenic diet. Genes Nutr, 8, 105-113.
17. Correll, C., Hauser, M., et al. (2010). Research in people with psychosis risk syndrome: A review of the current evidence and future directions. J Child Psychol Psychiatry Allied Discipl, 51, 390-431.
18. Cross-Disorder Group of the Psychiatric Genomics Consortium. (2013). Identifi cation of risk loci with shared effects on fi ve major psychiatric disorders: A genome-wide analysis. Lancet, 381, 1371-1379. doi: 10. 1016/S0140-6736(12)62129-1.
19. Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S. (2012). Functional annotation of the human brain methylome identifi es tissue-specifi c epigenetic variation across brain and blood. Genome Biol, 13, R43. doi: 10. 1186.
20. Dempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F., Kalidindi, S. (2011). Diseaseassociated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet, 20, 4786-4796.
21. Dong, E., Gavin, D., Chen., Y., & Davis, J. (2012). Upregulation of TET1 and down-regulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry, 2, e159. doi: 10. 1038/tp. 86.
22. Dong, E., Guidotti, A., Grayson, & Costa, E. (2007). Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A, 104, 4676-4681. (Pubitemid 47186284)
23. Fatemi, S. H., Earle, J. A., & McMenomy, T. (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry, 5, 654-663.
24. Favalli, G., Belmonte-de-Abreu, P., Wong, A. H., & Daskalakis, Z. J. (2012). The role of BDNF in the pathophysiolgy and treatment of schizophrenia. J Psychiatry Res, 46, 1-11.
25. Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A, 102, 10604-10649.
26. Gavin, D. P, Kartan, S., Chase, K., Jayaraman, S., & Sharma, R. P., (2009). Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res, 43, 870-876.
27. Gavin, D. E. P., Sharma, R. P., Chase, K. A., Matrisciano, F., Dong, E., & Guidotti, A. (2012). Growth arrest and DNA-damageinducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology, 2, 531-542.
28. Ghadirivasfi, M., Nohesara, S., Ahmadkhaniha, H. R., Eskandari, M. B., Mostafavi, S., & Thiagalingam, S. (2011). Hypomethylation of the serotonin receptor type 2A gene (HTR2A) at T102C plymorphic site in DNA derived from the sliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatry Genet, 156, 536-545.
29. Grayson D. R., & Guidotti, A. (2013). The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology, 38, 138-166.
30. Guidotti A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., et al. (2011). Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology, 60, 1007-1016.
31. Guidotti, A., Auta, J., Davis, J. M., Di Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch Gen Psychiatry, 57, 1061-1069.
32. Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., et al. (2005). GABAergic dysfunction in schizophrenia: New treatment strategies on the horizon [review]. Psychopharmacology (Berl), 180, 191-205. (Pubitemid 40909664)
33. Guidotti, A., Dong, E., Gavin, D. P., Veldic, M., Zhao, W., Bhaumik, D. K., et al. (2013). DNA methylation/demethylation network expression in psychotic patients with a history of alcohol abuse. Alcohol Clin Exp Res, 37, 417-424.
34. Guidotti, A., Ruzicka, W., Grayson, D. R., Veldic, M., Pinna, G., Davis, J. M., et al. (2007). S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport, 18, 57-60. (Pubitemid 46183390)
35. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., & Song, H. (2011). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell, 145, 423-434.
36. Guo, X., Zhai, J., Liu, Z., Fang, M., Wang, B., Wang, C., Hu, B., Sun, X., Lv, L., Lu Z., Ma, C., He, X., Guo, T., Xie, S., Wu, R., Xue, Z., Chen, J., Twamley, EW., Jin, H., & Zhao, J. (2010). Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study. Arch Gen Psychiatry, 67, 895-904.
37. Houston, I., Peter, C. J., Mitchell, A., Straubhaar, J., Rogaev, E., & Akbarian, S. (2013). Epigenetics in the human brain. Neuropsychopharmacology, 38, 183-197.
38. Ikegame, T., Bundo, M., Murata, Y., Kasai, K., Kato, T., & Iwamoto, K. (2013). DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet, 58, 434-438.
39. Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M. G., et al. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A, 95, 15718-15723. (Pubitemid 29018766)
40. Ito, S., D ' Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., & Zhang, Y. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specifi cation. Nature, 466, 1129-1133.
41. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama-Shigeno, Y., et al. (2005). DNA methylation status of Sox-10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci, 25, 5376-5381. (Pubitemid 40770917)
42. Jin, S. G., Wu, X., Li, A. X., & Pfeifer, G. P. (2011). Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res, 39, 5015-5024.
43. Keller, S., Sarchiapone, M., Zarrilli, F., Ferraro, A., Carli, V., et al. (2010). Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry, 67, 258-267.
44. Keller, S., Sarchiapone, M., Zarrilli, F., Tomaiuo, R., Carli, V., Angrisano, T., et al. (2011). TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. J Affect Disord, 135, 400-404.
45. Kriaucionis, S., & Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324, 929-930.
46. Labonte, B., Yerko, V., Gross, J., Mechawar, N., Meaney, M., Szyf, M., et al. (2012). Differential glucocorticoid receptor exon 1 b, 1 c, 1 h expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry, 72, 41-48.
47. Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F., et al. (2013). Comparative effi cacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet, 382, 951-962.
48. Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci, 6, 312-324. (Pubitemid 40469985)
49. Lim, U., & Song, M. A. (2012). Dietary and lifestyle factors of DNA methylation. Methods Mol Biol, 863, 359-376.
50. Liu, J., Chen, J., Ehrlich, S., Wolton, E., White, T., Perrone-Bizzozero, N. (2013). Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr Bull, Epub ahead of print. doi: 10. 1093/schbul/sbt080.
51. Liu, J., Morgan, M., Hutchison, K., & Calhoun, V. D. (2010). A study of the infl uence of sex on genome-wide methylation. PLoS ONE, 5, e10028.
52. Matrisciano, F., Tueting, P., Dalal, I., Kadriu, B., Grayson, D. R., Davis, J. M. (2013). Epigenetic modifi cations of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology, 68, 184-194.
53. McGlashan, T. H., Walsh, B. C., & Woods, S. W. (Eds.). (2010). The psychosis risk syndrome: Handbook of diagnosis and follow-up. Oxford, NY: Oxford University Press.
54. McGowan P. O., Sasaki A., D ' Alessio A. C., Dymov S., Labont é B., Szyf, M. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci, 12, 342-348.
55. Melas, P. A., Rogdaki, M., Osby, U., Schalling, M., Lavebratt, C., & Eksrtom, T. J. (2012). Epigenetic alterations in leukocytes of patients with schizohrenia: Association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J, 26, 2712-2718.
56. Mell é n, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell, 151, 1417-1430.
57. Michel, M., Schmidt, M. J., & Mirnics, K. (2012). Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol, 72, 1277-1287.
58. Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L. (2008). Epigenomic profi ling reveals DNAmethylation changes associated with major psychosis. Am J Hum Genet, 82, 696-711. (Pubitemid 351726115)
59. Mizrahi, R., Addington, J., Rusjan, P., Suridjan, I., Ng, A., Boileau, I. (2012). Increased stress-induced dopamine release in psychosis. Biol Psychiatry, 71, 561-567.
60. Morgan, H. D, Dean, W., Coker, H. A., Reik, W., & Petersen-Mahrt, S. K. (2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J Biol Chem, 279, 52353-52360. (Pubitemid 39656611)
61. Nishioka, M., Bundo, M., Koike, S., Takizawa, R., Kakiuchi, C., Araki, T., et al. (2012). Comprehensive DNA methylation analyses of peripheral blood cells derived from patients with fi rst episode schizophrenia. J Hum Genet, 58, 91-97.
62. Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M. B., Ahmadkhaniha, H. R., & Thiagalingam, S. (2011). DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder J Psychiatry, 45, 1432-1438.
63. Ouko, L. A., Shantikumar, K., Knezovich, J., Haycock, P., Schnugh, D. J., & Ramsay, M. (2009). Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H-19 and IG-DMR in male gametes: Implications for fetal alcohol spectrum disorders. Alcohol Clin Exp Res, 33, 1615-1627.
64. Ptak, C, & Petronis, A. (2008). Epigenetics and complex disease: From etiology to new therapeutics. Annu Rev Pharmacol Toxicol, 48, 257-276. (Pubitemid 351738154)
65. Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. 2005). Relationship between duration of untreated psychosis and outcome in fi rst-episode schizophrenia: A critical review and meta-analysis [review]. Am J Psychiatry, 162, 1785-804. (Pubitemid 41428609)
66. Philibert, R. A., Plume, J. M., Gibbons, F. X., Brody, G. H., & Beach, S. R., (2012). The impact of recent alcohol use on genome-wide DNA methylation signatures. Front Genet, 3, 54.
67. Provencal, N., Sudermsn, M. J., Guillemin, C., Massart, R., Ruggiero, A., Wang, D. (2012). The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. J Neurosci, 32, 15626-15642.
68. Rai, K., Huggins, I. J., James, S. R., Karpf, A. R., Jones, D. A., & Cairns, B. R. (2008). DNA demethylation in zebrafi sh involves the coupling of a deaminase, a glycosylase, and gadd45. Cell, 135, 1201-1212.
69. Rao, J. S., Keleshian, V. L., Klein, S., & Rapoport, S. I. (2012). Epigenetic modifi cations in frontal cortex from Alzheimer ' s disease and bipolar disorder patients. Transl Psychiatry, 2, e132.
70. Reinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlen, S. E., Greco, D. (2012). Differential DNA methylation in purifi ed human blood cels: Implications for cell lineage and studies on disease susceptibility. PLoS ONE, 7, e41361.
71. Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009). Epigenetic mechanisms in schizophrenia [review]. Biochim Biophys Acta, 1790, 869-877.
72. Ruzicka, W. B., Zhubi, A., Veldic, M., Grayson, D. R., Costa, E., & Guidotti, A. (2007). Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laserassisted microdissection. Mol Psychiatry, 4, 385-397. (Pubitemid 46496836)
73. Satta, R., Maloku, E., Zhubi, A., Pibiri, F., Hajos, M., Costa, E. (2008). Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci U S A, 105, 16356-16361.
74. Sinclair, D., Tsai, S. Y., Woon, H. G., & Weickert, C. S. (2011). Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness. Neuropsychopharmacology, 36, 2698-2709.
75. Sinclair, D., Fullerton, J. M., Webster, M. J., & Weickert, C. S. (2012). Glucocorticoid receptor 1B and 1C mRNA transcript in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. PLoS ONE, 7, 1-11.
76. Shimabukuro, M., Sasaki, T., Imamura, A., Tsujita, T., Fuke, C., & Umekage, T., (2007). Global hypomethylation of peripheral leucocyte DNA in male patients with schizophrenia: A potential link between epigenetics and schizophrenia. J Psychiatry Res, 41, 1042-1046. (Pubitemid 47301941)
77. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
78. Tremolizzo, L., Doueiri, M. S., Dong, E., Grayson, D. R., Davis, J., Pinna, G. (2005). Valproate corrects the schizophrenia-like epigenetic behavioral modifi cations induced by methionine in mice. Biol Psychiatry, 57, 500-509. (Pubitemid 40311985)
79. Veldic, M., Guidotti, A., Maloku, E., Davis, J. M., & Costa, E. (2005). In psychosis, cortical interneurons overexpress DNA-methyltransferase I. Proc Natl Acad Sci U S A, 102, 2152-2157. (Pubitemid 40262027)
80. Veldic, M., Kadriu, B., Maloku, E., Agis-Balboa, R. C., Guidotti, A., Davis, J. M., et al. (2007). Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res, 91, 51-61.
81. Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert., C. S. (2002). Regional specifi city of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry, 7, 985-994. (Pubitemid 35333054)
82. Williams, K., Christensen, J., Pedersen, M. T., Johansen, J. V., Cloos, P. A., Rappsilber, J. (2011). TET1 and hydroxymethylcytosine in transcription and DNA methylation fi delity. Nature, 19, 343-348.
83. Wong, C. C. Y., Meaburn, E. L., Ronald, A., Price, T. S., Jeffries, A. R., Schalkwyk, L. C. (2013). Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioral traits. Mol Psychiatry, 19, 495-503.
84. Wong, J., Hyde, T. M., Cassano, H. L., Deep-Soboslay, A., Kleinman, J. E., & Weickert, C. S. (2010). Promoter specifi c alterations of brain derived neurotrophic factor mRNA in schizophrenia. Neuroscience, 169, 1071-1084.
85. Yu, M., Hon, G. C., Szulwach, K. E., Song, C. X., Zhang, L., Kim, A. (2012). Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell, 149, 1368-1380.
86. Zhang, T. Y., Labont é, B., Wen, X. L., Turecki, G., & Meaney, M. J. (2013). Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology, 38, 111-123.
87. Zhu, J. K. (2009). Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet, 43, 143-166.
88. Zhubi, A., Veldic, M., Puri, N. V., Kadriu, B., Caruncho, H., Loza, I. (2009). An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophr Res, 111, 115-122.
89. Zhubi, A., Chen, Y., Dong, E., Cook, EH., Guidotti, A., & Grayson, DR. (2014). Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl. Psychiatry, 4, e349.
90. Ziermans, T. B., Schothorst, P. F., Sprong, M., & van Engeland, H. (2011). Transition and remission in adolescents at ultrahigh risk for psychosis. Schizophr Res, 126, 58-64.